豚流行性下痢ワクチンの世界市場レポート 2024年

豚流行性下痢（PED）ワクチン市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR7.7％で22億5,000万米ドルに成長します。この予測期間における成長は、予防接種プログラムの重視、ワクチン開発パイプラインの拡大、豚の個体数の増加、コールドチェーン管理の重視、予防ヘルスケア対策の重要性に対する意識の高まりによるものです。この期間に予想される主な動向には、ワクチン送達デバイス技術における技術革新の進行、針を使わないソリューションへのシフト、個別化医療の進歩、自己投与ワクチンへの嗜好の高まり、動物ヘルスケアインフラと流通網の改善などが含まれます。

豚流行性下痢ワクチン市場の成長は、養豚の普及率の増加によって牽引されると予想されます。養豚には、食肉生産のための家畜豚の飼育、繁殖、出生から市場体重までの管理、豚肉製品の販売など、さまざまな活動が含まれます。養豚の増加は、豚肉に対する世界の需要、繁殖と管理方法の進歩、養豚技術の技術的改善、豚肉消費市場の拡大に起因しています。豚流行性下痢（PED）ワクチンは、養豚における集団発生を予防・管理する上で重要な役割を果たしています。通常、母豚の妊娠期間中に注射または経口投与されるこれらのワクチンは、初乳を介して生まれたばかりの子豚に受動免疫を与えます。2023年12月現在、米国農務省は米国の農場における豚と豚の数を約7,500万頭と報告しており、PEDワクチンの需要を押し上げる上で養豚が重要な役割を担っていることを裏付けています。

豚流行性下痢ワクチン分野の大手企業は、市場での地位を強化するために技術革新に注力しています。注目すべき開発のひとつは、豚パルボウイルス（PPV）ワクチンの登場であり、PPVによる豚の繁殖不全を予防するために設計されています。ベーリンガーインゲルハイムは2022年3月にReproCyc ParvoFLEXワクチンを発売し、PPVに起因する不妊症、死産、ミイラ化胎児、虚弱子豚に対する包括的な保護を提供しました。この革新的なワクチンは、高度な製剤と有効性により豚群の健康と生産性を向上させるという同社のコミットメントを強調するものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界の豚流行性下痢ワクチン市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の豚流行性下痢ワクチン市場の実績：規模と成長, 2018-2023
• 世界の豚流行性下痢ワクチン市場の予測：規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

• 世界の豚流行性下痢ワクチン市場：製品別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 生ワクチン
• 不活化ワクチン
• 世界の豚流行性下痢ワクチン市場：用途別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 子豚
• 成豚
• 世界の豚流行性下痢ワクチン市場：エンドユーザー別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 動物病院
• 養豚農場

第7章 地域別・国別分析

• 世界の豚流行性下痢ワクチン市場：地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 世界の豚流行性下痢ワクチン市場：国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 豚流行性下痢ワクチン市場：競合情勢
• 豚流行性下痢ワクチン市場：企業プロファイル
  • Zoetis Inc.
  • Merck Animal Health
  • Elanco Animal Health
  • Idexx Laboratories Inc.
  • Bio-Rad Laboratories Inc.

第31章 その他の大手企業と革新的企業

• Ceva Sante Animale Health Company
• Phibro Animal Health Corporation
• Benchmark Animal Health Ltd.
• IDT Biologika GmbH
• Vaxxinova
• Qilu Animal Health Products Factory Co. Ltd.
• Tecnovax
• Green Cross Veterinary Products Co. Ltd.
• Nisseiken Co. Ltd.
• Komipharm International Co. Ltd.
• Boehringer Ingelheim Animal Health
• MSD Animal Health
• Ourofino Saude Animal
• Medgene Labs
• Harrisvaccines Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

Porcine epidemic diarrhea (PED) vaccines are formulated to confer immunity against the porcine epidemic diarrhea virus (PEDV), which causes severe gastrointestinal illness in pigs. These vaccines play a crucial role in preventing and managing outbreaks of Porcine Epidemic Diarrhea, thereby safeguarding the health and productivity of pig populations and ensuring the economic stability of the swine industry.

The primary types of porcine epidemic diarrhea vaccines are live vaccines and killed vaccines. Live vaccines contain attenuated or weakened forms of the PEDV virus. They are utilized in diverse settings, including piglets and adult pigs, across veterinary hospitals and hog production farms.

The porcine epidemic diarrhea vaccines market research report is one of a series of new reports from The Business Research Company that provides porcine epidemic diarrhea vaccines market statistics, including porcine epidemic diarrhea vaccines industry global market size, regional shares, competitors with a porcine epidemic diarrhea vaccines market share, detailed porcine epidemic diarrhea vaccines market segments, market trends, and opportunities, and any further data you may need to thrive in the porcine epidemic diarrhea vaccines industry. This porcine epidemic diarrhea vaccines research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The porcine epidemic diarrhea vaccines market size has grown strongly in recent years. It will grow from $1.56 billion in 2023 to $1.67 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historical period can be attributed to factors such as large-scale vaccination campaigns, expanded immunization programs (EPI), the adoption of disposable syringes, efforts to eradicate diarrhea, and initiatives such as the global alliance for vaccines and immunization (GAVI).

The porcine epidemic diarrhea vaccines market size is expected to see strong growth in the next few years. It will grow to $2.25 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be credited to increased emphasis on immunization programs, expansion of vaccine development pipelines, growing pig populations, focus on cold chain management, and rising awareness about the importance of preventive healthcare measures. Major trends anticipated during this period include ongoing innovations in vaccine delivery device technology, a shift towards needle-free solutions, advancements in personalized medicine, increasing preference for self-administered vaccines, and improvements in animal healthcare infrastructure and distribution networks.

The growth of the porcine epidemic diarrhea vaccines market is expected to be driven by the increasing prevalence of pig farming. Pig farming encompasses various activities such as raising domestic pigs for meat production, breeding, managing from birth to market weight, and marketing pork products. This rise in pig farming is attributed to global demand for pork, advancements in breeding and management practices, technological improvements in farming techniques, and expanding pork consumption markets. Porcine epidemic diarrhea (PED) vaccines play a crucial role in preventing and managing outbreaks in pig farming. Typically administered through injection or orally during the sow's gestation period, these vaccines confer passive immunity to newborn piglets via colostrum. As of December 2023, the United States Department of Agriculture reported approximately 75.0 million hogs and pigs on American farms, underscoring the significant role of pig farming in boosting the demand for PED vaccines.

Leading companies in the porcine epidemic diarrhea vaccines sector are focusing on innovation to strengthen their market positions. One notable development is the introduction of the porcine parvovirus (PPV) vaccine, designed to prevent reproductive failures in pigs caused by PPV. Boehringer Ingelheim launched the ReproCyc ParvoFLEX vaccine in March 2022, which offers comprehensive protection against infertility, stillbirths, mummified fetuses, and weak piglets resulting from PPV. This innovative vaccine underscores the company's commitment to enhancing the health and productivity of pig herds through advanced formulation and efficacy.

In September 2021, Vaxxinova International BV acquired Newport Laboratories from Boehringer Ingelheim, aiming to bolster its position in the animal health industry. Newport Laboratories specializes in custom-made vaccines for swine and cattle, aligning with Vaxxinova's goal to expand its portfolio of vaccines and diagnostic products, particularly in the swine sector. Newport Laboratories is a US-based company that manufactures custom-made vaccines for swine and cattle.

Major companies operating in the porcine epidemic diarrhea vaccines market are Zoetis Inc., Merck Animal Health, Elanco Animal Health, Idexx Laboratories Inc., Bio-Rad Laboratories Inc., Ceva Sante Animale Health Company, Phibro Animal Health Corporation, Benchmark Animal Health Ltd., IDT Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Tecnovax, Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Komipharm International Co. Ltd., Boehringer Ingelheim Animal Health, MSD Animal Health, Ourofino Saude Animal, Medgene Labs, Harrisvaccines Inc

Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2023. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the porcine epidemic diarrhea vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The porcine epidemic diarrhea vaccines market consists of sales of ingelvac PEDV, barricade, PED vax, PEDV shield, and enterisol ileitis. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Porcine Epidemic Diarrhea Vaccines Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on porcine epidemic diarrhea vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for porcine epidemic diarrhea vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The porcine epidemic diarrhea vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Live Vaccines; Killed Vaccines
• 2) By Application: Piglets; Adults Pigs
• 3) By End-User: Veterinary Hospitals; Hog Production Farms
• Companies Mentioned: Zoetis Inc.; Merck Animal Health; Elanco Animal Health; Idexx Laboratories Inc.; Bio-Rad Laboratories Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Porcine Epidemic Diarrhea Vaccines Market Characteristics

3. Porcine Epidemic Diarrhea Vaccines Market Trends And Strategies

4. Porcine Epidemic Diarrhea Vaccines Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Porcine Epidemic Diarrhea Vaccines Market Size and Growth

• 5.1. Global Porcine Epidemic Diarrhea Vaccines Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Porcine Epidemic Diarrhea Vaccines Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Porcine Epidemic Diarrhea Vaccines Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Porcine Epidemic Diarrhea Vaccines Market Segmentation

• 6.1. Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Live Vaccines
• Killed Vaccines
• 6.2. Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Piglets
• Adults Pigs
• 6.3. Global Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Veterinary Hospitals
• Hog Production Farms

7. Porcine Epidemic Diarrhea Vaccines Market Regional And Country Analysis

• 7.1. Global Porcine Epidemic Diarrhea Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Porcine Epidemic Diarrhea Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market

• 8.1. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Porcine Epidemic Diarrhea Vaccines Market

• 9.1. China Porcine Epidemic Diarrhea Vaccines Market Overview
• 9.2. China Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Porcine Epidemic Diarrhea Vaccines Market

• 10.1. India Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Porcine Epidemic Diarrhea Vaccines Market

• 11.1. Japan Porcine Epidemic Diarrhea Vaccines Market Overview
• 11.2. Japan Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Porcine Epidemic Diarrhea Vaccines Market

• 12.1. Australia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Porcine Epidemic Diarrhea Vaccines Market

• 13.1. Indonesia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Porcine Epidemic Diarrhea Vaccines Market

• 14.1. South Korea Porcine Epidemic Diarrhea Vaccines Market Overview
• 14.2. South Korea Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Porcine Epidemic Diarrhea Vaccines Market

• 15.1. Western Europe Porcine Epidemic Diarrhea Vaccines Market Overview
• 15.2. Western Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Porcine Epidemic Diarrhea Vaccines Market

• 16.1. UK Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Porcine Epidemic Diarrhea Vaccines Market

• 17.1. Germany Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Porcine Epidemic Diarrhea Vaccines Market

• 18.1. France Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Porcine Epidemic Diarrhea Vaccines Market

• 19.1. Italy Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Porcine Epidemic Diarrhea Vaccines Market

• 20.1. Spain Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market

• 21.1. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market Overview
• 21.2. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Porcine Epidemic Diarrhea Vaccines Market

• 22.1. Russia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Porcine Epidemic Diarrhea Vaccines Market

• 23.1. North America Porcine Epidemic Diarrhea Vaccines Market Overview
• 23.2. North America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Porcine Epidemic Diarrhea Vaccines Market

• 24.1. USA Porcine Epidemic Diarrhea Vaccines Market Overview
• 24.2. USA Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Porcine Epidemic Diarrhea Vaccines Market

• 25.1. Canada Porcine Epidemic Diarrhea Vaccines Market Overview
• 25.2. Canada Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Porcine Epidemic Diarrhea Vaccines Market

• 26.1. South America Porcine Epidemic Diarrhea Vaccines Market Overview
• 26.2. South America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Porcine Epidemic Diarrhea Vaccines Market

• 27.1. Brazil Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Porcine Epidemic Diarrhea Vaccines Market

• 28.1. Middle East Porcine Epidemic Diarrhea Vaccines Market Overview
• 28.2. Middle East Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Porcine Epidemic Diarrhea Vaccines Market

• 29.1. Africa Porcine Epidemic Diarrhea Vaccines Market Overview
• 29.2. Africa Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Porcine Epidemic Diarrhea Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Porcine Epidemic Diarrhea Vaccines Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Porcine Epidemic Diarrhea Vaccines Market Competitive Landscape And Company Profiles

• 30.1. Porcine Epidemic Diarrhea Vaccines Market Competitive Landscape
• 30.2. Porcine Epidemic Diarrhea Vaccines Market Company Profiles
  • 30.2.1. Zoetis Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Merck Animal Health
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Elanco Animal Health
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Idexx Laboratories Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Bio-Rad Laboratories Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Porcine Epidemic Diarrhea Vaccines Market Other Major And Innovative Companies

• 31.1. Ceva Sante Animale Health Company
• 31.2. Phibro Animal Health Corporation
• 31.3. Benchmark Animal Health Ltd.
• 31.4. IDT Biologika GmbH
• 31.5. Vaxxinova
• 31.6. Qilu Animal Health Products Factory Co. Ltd.
• 31.7. Tecnovax
• 31.8. Green Cross Veterinary Products Co. Ltd.
• 31.9. Nisseiken Co. Ltd.
• 31.10. Komipharm International Co. Ltd.
• 31.11. Boehringer Ingelheim Animal Health
• 31.12. MSD Animal Health
• 31.13. Ourofino Saude Animal
• 31.14. Medgene Labs
• 31.15. Harrisvaccines Inc.

32. Global Porcine Epidemic Diarrhea Vaccines Market Competitive Benchmarking

33. Global Porcine Epidemic Diarrhea Vaccines Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Porcine Epidemic Diarrhea Vaccines Market

35. Porcine Epidemic Diarrhea Vaccines Market Future Outlook and Potential Analysis

• 35.1 Porcine Epidemic Diarrhea Vaccines Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Porcine Epidemic Diarrhea Vaccines Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Porcine Epidemic Diarrhea Vaccines Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer